Skip to Main Content
Alagpulinsa Laboratory
YSM Home

INFORMATION FOR

Selected Publications

*denotes corresponding author; $denotes equal contribution

  1. Adebekun J, Nadig A, Saarah P, Asgari S, Kachuri L, and Alagpulinsa DA*. Genetic relations between leukocyte counts, type 1 diabetes, and coronary artery disease. medRxiv, 2024: p. 2024.04.01.24305155.
  2. Robinson JA, Toribio M, Quinaglia T, Awadalla M, Talathi R, Durbin CG, Alhallak I, Alagpulinsa DA, Fourman LT, Suero-Abreu GA, Nelson MD, Stanley LT, Longenecker CT, Szczepaniak LS, Jerosch-Herold M, Neilan TG, Zanni MV, Burdo TH. Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIV. AIDS. 2023; 37(2):305-310. PMID: 36541642.
  3. Alagpulinsa DA*, Toribio MP, Iad A and Shmookler Reis RJ. Advances in understanding the molecular basis of clonal hematopoiesis. Trends in Molecular Medicine, 2022. 28(5):360-377. PMID: 35341686.
  4. Alagpulinsa DA*, Szalat R, Poznansky MC, Shmookler Reis RJ. Genomic instability in multiple myeloma. Trends in Cancer, 2020; S2405-8033(20)30161-8. PMID: 32487486,
  5. Alolga RN$, Opoku-Damoah Y$, Alagpulinsa DA$, Huang FQ, Ma G, Yin X, Chavez MASC, Kudzai LC, Qi LW, Ding Y. Metabolomic and transcriptomic analyses of the anti-Rheumatoid Arthritis potential of xylopic acid in a bioinspired nanoformulation. Biomaterials, 2021, 268: p. 120482. PMID: 33307367.
  6. Alagpulinsa DA, Cao JLL, Driscoll RK, Sȋbulescu RF, Penson MFE, Sremac M, Engquist EN, Brauns T, Markmann JF, Melton DA, Poznansky MC. Alginate-microencapsulation of human stem cell-derived β cells prolongs their survival and function in immunocompetent mice without immunosuppression. American Journal of Transplantation, 2019; 19(7):1930-1940. PMID: 30748094.
  7. Alagpulinsa DA, Kumar S, Talluri S, Nanjappa P, Buon L, Chakraborty C, Samur M, Szalat R, Shammas MA, Munshi NC. Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma. Blood Advances, 2019; 3(23):3968-3972. PMID: 31805191.
  8. Alagpulinsa DA, Cao JLL, Sobell D, Poznansky MC. Harnessing CXCL12 signaling to protect and preserve functional beta-cell mass and for cell replacement in type 1 diabetes. Pharmacology & Therapeutics. 2019; 193:63-74. PMID: 30149101.
  9. Alagpulinsa DA, Ayyadevara S, Yaccoby S, Shmookler Reis RJ. A cyclin-dependent kinase inhibitor, dinaciclib, impairs homologous recombination and sensitizes multiple myeloma cells to PARP inhibition. Molecular Cancer Therapeutics, 2016; 15(2):241-250. PMID: 26719576.